An electroretinogram (ERG) is a test that measures the electrical activity generated by the retina of the eye in response to a light stimulus. It is used by eye doctors to find problems with the retina or the pathway between the retina and brain. As retinal diseases and conditions can impact quality of life and vision across all age groups, ERGs are an important diagnostic tool globally. However, access is limited in underserved parts of the world. This article explores recent efforts to increase Electroretinogram testing worldwide through innovative technologies and mobile clinics.
What is an Electroretinogram test?
An Electroretinogram test works by placing electrode contact lenses or skin electrodes near the eyes. Bursts of light are then presented to the retina while electrodes record the retina’s electrical response. There are two main types of ERG. A flash Electroretinogram tests the overall function of the retina by recording responses to a brief, intense flash of light. Pattern ERGs assess finer visual details by presenting a grid-like pattern on a screen. Changes in the waveform or amplitude of responses can indicate underlying retinal diseases. Some common retinal conditions diagnosed with ERGs include retinitis pigmentosa, diabetic retinopathy, macular degeneration and optic neuropathy.
Increasing global Electroretinogram testing with newer technologies
Traditional Electroretinogram Machines are large, costly devices mostly located in hospitals and eye clinics. As a result, many rural and low-resource areas lack access to this important screening and diagnostic tool. Newer portable Electroretinogram devices aim to close this gap. Companies like Metrovision and Diagnosys have developed handheld units small enough to carry into the field. They can perform flash and pattern ERGs without needing dedicated darkroom facilities. Some models use wireless technology to transmit results to off-site experts for remote interpretation. These portable ERGs are being utilized by mobile eye screening programs worldwide.
For example, non-profit organizations like Vineyard Eyes and Optometric Africa have introduced portable ERGs to their mobile clinics in sub-Saharan Africa and Asia. By bringing eye care directly to underserved communities, they have been able to screen thousands for retinal diseases who otherwise may never have access to an eye exam. In rural India, portable ERGs have assisted eye hospitals with outreach camps to efficiently diagnose patients from remote villages. As the technology advances further, the goal is for portable ERGs to become more affordable and easily deployable anywhere eye care is needed.
Expanding Electroretinogram use through telemedicine platforms
Advances are also being made in using telemedicine to widen the reach of Electroretinogram testing. With connectivity now extending to remote areas, virtual platforms allow convenient sharing of Electroretinogram data between locations. Eye clinics in higher-resource regions can assist those in developing countries by providing remote interpretation. For instance, UK-based eye hospitals have partnered with African counterparts to offer tele-ophthalmology services, including online Electroretinogram interpretation. US organizations have collaborated similarly with Latin American clinics.
With computers and scanners, Electroretinogram waveforms can be digitally uploaded and transmitted over secure networks. Ophthalmologists at tertiary centres then analyse the recordings and provide diagnostic feedback to local clinicians. This tele-Electroretinogram model has proven effective for retinal specialists to deliver timely Electroretinogram consultation to underserved populations worldwide. It mitigates distance barriers while increasing diagnostic capabilities of clinics. As telemedicine platforms integrate artificial intelligence, automated analysis of Electroretinogram waveforms may become possible as well. This could make virtual Electroretinogram interpretation scalable to an even larger global audience.
Standardization for improved global comparisons
As Electroretinogram testing expands internationally, efforts are also underway to standardize protocols and parameters. Variations in equipment, stimulus settings and waveform analysis between regions can challenge reliable cross-country comparisons. The International Society for Clinical Electrophysiology of Vision aims to address this through guidelines developed by expert consensus. They recommend protocols for consistent flash and pattern Electroretinogram administration and interpretation. Adopting standardized procedures assists collaborative research initiatives evaluating ERGs from different global populations.
It also permits tracking disease trends across diverse regions. For example, a global Electroretinogram registry established by the ORA Foundation collects retinal function metrics from studies worldwide using standardized techniques. Comparing longitudinal Electroretinogram data may provide insights into geographic or ethnic differences in retinal conditions. Standardization can further aid clinical trials assessing new therapies by harmonizing outcome measures between international sites. As ERGs assume a larger role in global eye care, establishing common protocols is crucial for optimizing this technology’s research and diagnostic applications internationally.
Electroretinography plays an important part in detecting and managing retinal diseases worldwide. However, limited access has historically hindered its global application. Innovations in portable technologies and telemedicine platforms now present opportunities for more widespread Electroretinogram testing. Mobile eye clinics deploying handheld Electroretinogram devices are bringing retinal screening directly to underserved communities globally. Meanwhile, virtual modalities like tele-Electroretinogram consultations allow enhancing diagnostic capabilities regionally. Standardizing protocols also supports research collaboration and monitoring retinal health trends internationally. Continued advancements aim to make Electroretinogram testing accessible anywhere eye care is needed. Combined with optimized screening techniques, ERGs show promise for improving detection of sight-threatening retinal conditions on a global scale.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it